Isothermal Nucleic Acid Amplification Technology Market by Product, Type, Application, End-User

Description

List of Tables

The Isothermal Nucleic Acid Amplification Technology Market was valued at USD 3.77 billion in 2023, expected to reach USD 4.25 billion in 2024, and is projected to grow at a CAGR of 13.64%, to USD 9.22 billion by 2030.

Isothermal Nucleic Acid Amplification Technology (INAAT) represents a crucial advancement in molecular diagnostics, offering a robust and user-friendly method for the amplification of nucleic acids without the need for thermal cycling, as in traditional PCR methods. Its necessity arises from its ability to provide rapid, sensitive, and specific pathogen detection directly at the point of care, pivotal for public health, especially during disease outbreaks. The technology finds diverse applications in clinical diagnostics, food safety testing, and pathogen detection in agriculture. The end-use scope spans hospitals, diagnostic labs, research institutions, and food safety agencies. Key growth influencers in this market include the heightened demand for rapid diagnostic solutions, the rise in infectious diseases, and the expansion of applications in emerging markets. Recent advances in portable device development and integration with digital technology for real-time analysis present substantial growth opportunities. To capitalize on these, businesses can focus on partnerships with healthcare providers and digital solution developers to enhance accessibility and functionality. Market constraints include high initial costs and technical challenges in standardizing INAAT protocols across different platforms. Regulatory hurdles can also pose significant barriers to market entry, slowing the widespread adoption of new INAAT products. The market would benefit from innovations such as the development of low-cost, portable point-of-care devices that offer real-time connectivity and enhanced specificity in detection. Expanding the application range of INAAT by exploring synergies with CRISPR-based detection systems and advancing automation of sample processing also represent promising areas for research and innovation. The nature of the INAAT market is dynamic and competitive, shaped by ongoing technological innovations and a strong emphasis on meeting unmet diagnostic needs in various sectors. Businesses poised to leverage these trends are likely to gain significant traction in this growing market.

KEY MARKET STATISTICS
Base Year [2023]	USD 3.77 billion
Estimated Year [2024]	USD 4.25 billion
Forecast Year [2030]	USD 9.22 billion
CAGR (%)	13.64%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Isothermal Nucleic Acid Amplification Technology Market

The Isothermal Nucleic Acid Amplification Technology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Rising prevalence of antimicrobial and infectious diseases worldwide
- Increasing adoption of INAAT for accurate & rapid testing results
- Development of miniaturized nucleic acid-based diagnostics
Market Restraints
- High cost of reagents and implementation of technology
Market Opportunities
- Technological advancements in isothermal nucleic acid amplification
- Increasing adoption of digital diagnostics and rising demand for point-of-care diagnostics solutions
Market Challenges
- Limitation of isothermal nucleic acid amplification technology

Porter's Five Forces: A Strategic Tool for Navigating the Isothermal Nucleic Acid Amplification Technology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Isothermal Nucleic Acid Amplification Technology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Isothermal Nucleic Acid Amplification Technology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Isothermal Nucleic Acid Amplification Technology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Isothermal Nucleic Acid Amplification Technology Market

A detailed market share analysis in the Isothermal Nucleic Acid Amplification Technology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Isothermal Nucleic Acid Amplification Technology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Isothermal Nucleic Acid Amplification Technology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Isothermal Nucleic Acid Amplification Technology Market

A strategic analysis of the Isothermal Nucleic Acid Amplification Technology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Isothermal Nucleic Acid Amplification Technology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AtilaBiosystems, Beijing SBS Genetech Co., Ltd., bioMerieux SA, Biosearch Technologies by LGC Limited, DiaSorin S.p.A., Eiken Chemical Co., Ltd., Fortis Life Sciences, LLC, GENOMTEC S.A., GenoSensor Corporation, Grifols S.A., highQu GmbH, Hologic, Inc., Illumina, Inc., Jena Bioscience GmbH, Life Sciences Advanced Technologies, Inc., Mast Group Ltd., Meridian Bioscience Inc. by SD Biosensor, Inc., New England Biolabs, Inc., OptiGene Limited, PCR Biosystems Ltd., QIAGEN GmbH, Quidel Corporation, Tecan Trading AG, Thermo Fisher Scientific Inc., Ustar Biotechnologies (Hangzhou) Ltd, Xiamen Jiqing Biomedical Technology Co., Ltd., Zhengzhou Laboao Instrument Equipment CO., LTD, and Zhuhai Biori Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Isothermal Nucleic Acid Amplification Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Product, market is studied across Assays, Kits, & Reagents and Systems.
Based on Type, market is studied across Helicase-dependent Amplification, Loop-mediated Isothermal Amplification, Nucleic Acid Sequence-based Amplification, Strand Displacement Amplification, and Transcription-mediated Amplification.
Based on Application, market is studied across Blood Screening and Disease Diagnosis. The Disease Diagnosis is further studied across CT/NG, Hepatitis, HIV, and Influenza.
Based on End-User, market is studied across Academic & Research Institutes, Hospitals, and Reference Laboratories.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-B9334AD6C2E2

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of antimicrobial and infectious diseases worldwide
  - 5.1.1.2. Increasing adoption of INAAT for accurate & rapid testing results
  - 5.1.1.3. Development of miniaturized nucleic acid-based diagnostics
- 5.1.2. Restraints
  - 5.1.2.1. High cost of reagents and implementation of technology
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancements in isothermal nucleic acid amplification
  - 5.1.3.2. Increasing adoption of digital diagnostics and rising demand for point-of-care diagnostics solutions
- 5.1.4. Challenges
  - 5.1.4.1. Limitation of isothermal nucleic acid amplification technology
5.2. Market Segmentation Analysis
- 5.2.1. Product: Advancements in isothermal nucleic acid amplification technology systems to scale up their operations and automate their workflows
- 5.2.2. Type: Growing preference for transcription-mediated amplification in clinical diagnostics for its rapid and high amplification capacity
- 5.2.3. Application: Extensive utilization of isothermal nucleic acid amplification technology for disease diagnoses for promoting better patient outcomes
- 5.2.4. End-User: Significant role of isothermal nucleic acid amplification technology in hospitals for rapid and accurate diagnostics to improve patient care
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Isothermal Nucleic Acid Amplification Technology Market, by Product

6.1. Introduction
6.2. Assays, Kits, & Reagents
6.3. Systems

7. Isothermal Nucleic Acid Amplification Technology Market, by Type

7.1. Introduction
7.2. Helicase-dependent Amplification
7.3. Loop-mediated Isothermal Amplification
7.4. Nucleic Acid Sequence-based Amplification
7.5. Strand Displacement Amplification
7.6. Transcription-mediated Amplification

8. Isothermal Nucleic Acid Amplification Technology Market, by Application

8.1. Introduction
8.2. Blood Screening
8.3. Disease Diagnosis
- 8.3.1. CT/NG
- 8.3.2. Hepatitis
- 8.3.3. HIV
- 8.3.4. Influenza

9. Isothermal Nucleic Acid Amplification Technology Market, by End-User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospitals
9.4. Reference Laboratories

10. Americas Isothermal Nucleic Acid Amplification Technology Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Polish biotech Genomtec raises EUR 2.9 million (USD 3.19 million) from share issue
- 13.3.2. Stilla Technologies and Atila BioSystems to Co-Develop High-Plex Digital PCR Kits for Oncology
- 13.3.3. Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics
- 13.3.4. Sherlock Biosciences and Tolo Biotech Expand Collaboration to Advance Development and Adoption of CRISPR-based Diagnostics
- 13.3.5. Ankur Capital invests in molecular diagnostic startup D-NOME
- 13.3.6. WeTrade and Jiqing Biomedical partner to sell monkeypox tests
- 13.3.7. Recombinase Polymerase Amplification, or RPA, is the breakthrough, isothermal replacement to PCR
- 13.3.8. Mawi iSWAB Microbiome-EL Enables Prime Discoveries' Development of Rapid Extraction-Less COVID Diagnostic Assay
- 13.3.9. Thermo Fisher introduces two RT-LAMP tests to detect viral pathogens
- 13.3.10. Medix Biochemica Acquires German MDx Raw Materials Producer MyPols Biotec
13.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Abbott Laboratories
2. AtilaBiosystems
3. Beijing SBS Genetech Co., Ltd.
4. bioMerieux SA
5. Biosearch Technologies by LGC Limited
6. DiaSorin S.p.A.
7. Eiken Chemical Co., Ltd.
8. Fortis Life Sciences, LLC
9. GENOMTEC S.A.
10. GenoSensor Corporation
11. Grifols S.A.
12. highQu GmbH
13. Hologic, Inc.
14. Illumina, Inc.
15. Jena Bioscience GmbH
16. Life Sciences Advanced Technologies, Inc.
17. Mast Group Ltd.
18. Meridian Bioscience Inc. by SD Biosensor, Inc.
19. New England Biolabs, Inc.
20. OptiGene Limited
21. PCR Biosystems Ltd.
22. QIAGEN GmbH
23. Quidel Corporation
24. Tecan Trading AG
25. Thermo Fisher Scientific Inc.
26. Ustar Biotechnologies (Hangzhou) Ltd
27. Xiamen Jiqing Biomedical Technology Co., Ltd.
28. Zhengzhou Laboao Instrument Equipment CO., LTD
29. Zhuhai Biori Biotechnology Co., Ltd.